MeSH D004831 - myoclonic epilepsies
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004829:Generalized epilepsy
0 Companies
0 Drugs
Success rate
D000073376:Epileptic syndromes
D004831:
Myoclonic epilepsies
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals | Cannabidiol | Epidiolex | 2022-05-07 | 2018-09-28 | $855.275 M | Q2/23-Q1/24 |
| Cannabidiol | Epidyolex | 2019-09-19 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
75%3/4
Phase 3
67%6/9
Approved: 4Overall Success rate: 50%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use